том 17 издание 6 страницы 563-579

Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential

Тип публикацииJournal Article
Дата публикации2018-04-20
scimago Q1
wos Q1
БС1
SJR1.555
CiteScore10.0
Impact factor5.3
ISSN1570159X, 18756190
General Medicine
Pharmacology
Pharmacology (medical)
Neurology
Psychiatry and Mental health
Neurology (clinical)
Краткое описание

Neurodegenerative diseases are among the most serious health problems affecting millions of people worldwide. Such diseases are characterized by a progressive degeneration and / or death of neurons in the central nervous system. Currently, there are no therapeutic approaches to cure or even halt the progression of neurodegenerative diseases. During the last two decades, much attention has been paid to the neuroprotective and anti-neurodegenerative activities of compounds isolated from natural products with high efficacy and low toxicity. Accumulating evidence indicates that berberine, an isoquinoline alkaloid isolated from traditional Chinese medicinal herbs, may act as a promising anti-neurodegenerative agent by inhibiting the activity of the most important pathogenic enzymes, ameliorating intracellular oxidative stress, attenuating neuroinflammation, triggering autophagy and protecting neurons against apoptotic cell death. This review attempts to summarize the current state of knowledge regarding the therapeutic potential of berberine against neurodegenerative diseases, with a focus on the molecular mechanisms that underlie its effects on Alzheimer’s, Parkinson’s and Huntington’s diseases.

Найдено 
Найдено 

Топ-30

Журналы

1
2
3
4
Frontiers in Pharmacology
4 публикации, 6.15%
International Journal of Molecular Sciences
3 публикации, 4.62%
Molecules
2 публикации, 3.08%
Heliyon
2 публикации, 3.08%
Food Science and Nutrition
2 публикации, 3.08%
BioFactors
2 публикации, 3.08%
International Journal of Biological Macromolecules
2 публикации, 3.08%
Journal of Alzheimer's Disease
1 публикация, 1.54%
Molecular Biotechnology
1 публикация, 1.54%
Journal of Neuroinflammation
1 публикация, 1.54%
NeuroReport
1 публикация, 1.54%
Biomolecules
1 публикация, 1.54%
Frontiers in Genetics
1 публикация, 1.54%
Frontiers in Oncology
1 публикация, 1.54%
Frontiers in Aging Neuroscience
1 публикация, 1.54%
Biocell
1 публикация, 1.54%
Plants
1 публикация, 1.54%
Natural Products and Bioprospecting
1 публикация, 1.54%
Journal of Functional Foods
1 публикация, 1.54%
European Journal of Pharmacology
1 публикация, 1.54%
Journal of Ethnopharmacology
1 публикация, 1.54%
Life Sciences
1 публикация, 1.54%
Journal of Drug Delivery Science and Technology
1 публикация, 1.54%
Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology
1 публикация, 1.54%
CNS and Neurological Disorders - Drug Targets
1 публикация, 1.54%
Food and Function
1 публикация, 1.54%
Evidence-based Complementary and Alternative Medicine
1 публикация, 1.54%
Current Molecular Pharmacology
1 публикация, 1.54%
Phytomedicine
1 публикация, 1.54%
1
2
3
4

Издатели

2
4
6
8
10
12
14
16
18
Elsevier
17 публикаций, 26.15%
Springer Nature
9 публикаций, 13.85%
MDPI
8 публикаций, 12.31%
Frontiers Media S.A.
8 публикаций, 12.31%
Wiley
8 публикаций, 12.31%
Bentham Science Publishers Ltd.
4 публикации, 6.15%
IOS Press
1 публикация, 1.54%
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 1.54%
Tech Science Press
1 публикация, 1.54%
Royal Society of Chemistry (RSC)
1 публикация, 1.54%
IntechOpen
1 публикация, 1.54%
Hindawi Limited
1 публикация, 1.54%
British Editorial Society of Bone and Joint Surgery
1 публикация, 1.54%
AME Publishing Company
1 публикация, 1.54%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 1.54%
SAGE
1 публикация, 1.54%
2
4
6
8
10
12
14
16
18
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
65
Поделиться
Цитировать
ГОСТ |
Цитировать
Fan D. et al. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential // Current Neuropharmacology. 2018. Vol. 17. No. 6. pp. 563-579.
ГОСТ со всеми авторами (до 50) Скопировать
Fan D., Liu L., Wu Z., Meiqun C. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential // Current Neuropharmacology. 2018. Vol. 17. No. 6. pp. 563-579.
RIS |
Цитировать
TY - JOUR
DO - 10.2174/1570159x16666180419141613
UR - https://doi.org/10.2174/1570159x16666180419141613
TI - Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
T2 - Current Neuropharmacology
AU - Fan, Dahua
AU - Liu, Liping
AU - Wu, Zhengzhi
AU - Meiqun, Cao
PY - 2018
DA - 2018/04/20
PB - Bentham Science Publishers Ltd.
SP - 563-579
IS - 6
VL - 17
PMID - 29676231
SN - 1570-159X
SN - 1875-6190
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2018_Fan,
author = {Dahua Fan and Liping Liu and Zhengzhi Wu and Cao Meiqun},
title = {Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential},
journal = {Current Neuropharmacology},
year = {2018},
volume = {17},
publisher = {Bentham Science Publishers Ltd.},
month = {apr},
url = {https://doi.org/10.2174/1570159x16666180419141613},
number = {6},
pages = {563--579},
doi = {10.2174/1570159x16666180419141613}
}
MLA
Цитировать
Fan, Dahua, et al. “Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.” Current Neuropharmacology, vol. 17, no. 6, Apr. 2018, pp. 563-579. https://doi.org/10.2174/1570159x16666180419141613.